Pelvic Lymph Node Dissection in Bladder Cancer: Have We Agreed on the Extent?
UroCancer Clinics of India · 2024
DOI: 10.4103/ucci.ucci_18_24 ↗Kurz gefasst
Fachartikel in der Zeitschrift UroCancer Clinics of India, 2024. Verfasst von Anshuman Singh und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Radical cystectomy (RC) combined with pelvic lymph node dissection (PLND) is the gold standard for treating muscle invasive bladder cancer; however, the optimal extent of PLND, whether limited (lPLND), standard (sPLND), extended (ePLND), or super-extended (sePLND), remains controversial. This review assesses the existing literature, including randomized controlled trials, retrospective studies, and meta-analyses, to evaluate the impact of different PLND extents on oncological and survival outcomes in patients undergoing RC. For patients with advanced disease (cT3 or higher), ePLND provides significant diagnostic and therapeutic benefits by improving staging accuracy and potentially eradicating micrometastatic disease, which may translate into better survival outcomes. The advantages of ePLND often outweigh the associated surgical risks in such cases. Conversely, for patients with less advanced disease (≤pT2) or those with significant comorbidities, the incremental benefits of extensive dissection are limited, and a more conservative approach, such as lPLND or sPLND, is recommended to minimize surgical morbidity when still achieving effective oncologic control. Current evidence suggests that a well-performed sPLND is generally sufficient for accurate staging and prognostication, whereas sePLND does not offer additional survival benefits and increases the risk of complications.
Zitieren
APA
Singh, A., Sharma, G., & Gautam, G. (2024). Pelvic Lymph Node Dissection in Bladder Cancer: Have We Agreed on the Extent?. UroCancer Clinics of India. https://doi.org/10.4103/ucci.ucci_18_24
Vancouver
Singh A, Sharma G, Gautam G. Pelvic Lymph Node Dissection in Bladder Cancer: Have We Agreed on the Extent?. UroCancer Clinics of India. 2024. doi:10.4103/ucci.ucci_18_24
BibTeX
@article{Singh2024,
author = {Singh, Anshuman and Sharma, Gopal and Gautam, Gagan},
title = {Pelvic Lymph Node Dissection in Bladder Cancer: Have We Agreed on the Extent?},
journal = {UroCancer Clinics of India},
year = {2024},
doi = {10.4103/ucci.ucci_18_24}
}
EUVIMED